Huron Consulting Group (NASDAQ:HURN) Releases FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 6.800-7.600 for the period, compared to the consensus estimate of 6.950. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Analyst Ratings Changes

A number of analysts recently commented on HURN shares. Barrington Research upped their price objective on shares of Huron Consulting Group from $142.00 to $167.00 and gave the company an “outperform” rating in a research report on Thursday. StockNews.com upgraded Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Benchmark lifted their price target on shares of Huron Consulting Group from $140.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday. Truist Financial reissued a “buy” rating and set a $165.00 price objective (up previously from $140.00) on shares of Huron Consulting Group in a research report on Wednesday. Finally, Wedbush assumed coverage on shares of Huron Consulting Group in a research note on Monday, February 3rd. They issued an “outperform” rating for the company. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $151.75.

Huron Consulting Group Stock Up 0.9 %

HURN stock traded up $1.40 during mid-day trading on Thursday, reaching $149.58. The company had a trading volume of 363,689 shares, compared to its average volume of 130,137. Huron Consulting Group has a 52 week low of $84.26 and a 52 week high of $153.77. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of 32.52 and a beta of 0.59. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a 50 day simple moving average of $126.33 and a two-hundred day simple moving average of $117.59.

Huron Consulting Group (NASDAQ:HURN) last posted its quarterly earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $0.38. The firm had revenue of $399.31 million for the quarter, compared to analyst estimates of $380.62 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. As a group, equities analysts predict that Huron Consulting Group will post 6.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $122.81, for a total transaction of $127,968.02. Following the completion of the sale, the director now owns 26,756 shares of the company’s stock, valued at approximately $3,285,904.36. The trade was a 3.75 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John Mccartney sold 500 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.65, for a total transaction of $62,325.00. Following the sale, the director now owns 56,688 shares of the company’s stock, valued at $7,066,159.20. This trade represents a 0.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,584 shares of company stock valued at $1,067,539 over the last 90 days. 2.02% of the stock is currently owned by insiders.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.